The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy

Zhi-Peng Wang; Ai-Qing Li; Dilinaer Wusiman; Rui-Cheng Wu; Ji-Min Zhu; Xin-Rui Li; Yuan-Ning Guo; Premkamon Chaipanichkul; Uzoamaka Adaobi Okoli; Siang Boon Koh; Jie Wang; Deng-Xiong Li; Xiao-Dong Jin; Da-Hong Zhang; Cheema Umber; Qi Zhang; De-Chao Feng

doi:10.1016/j.mmr.2026.100038

Your Location：

Home >

Browse articles >

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy

REVIEW | Updated：2026-06-12

- The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
- Military Medical Research (2026)
- Affiliations：
  
  Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China
  The Center of Psychosomatic Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China
  Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN 47907, USA
  Division of Surgery & Interventional Science, University College London, London W1W 7TS, UK
  Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
  Department of Gastroenterology and Hepatology and Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China
  Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel
  Department of Radiology, Division of Radiation Oncology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
  Basic and Translational Cancer Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu 340001, Nigeria
  Faculty of Health and Life Sciences, University of Bristol, Bristol BS8 1TD, UK
  Department of Urology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310009, China
  Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou 310014, China
- Author bio：
  
  Da-Hong Zhang, urology@zju.edu.cn
  Cheema Umber, u.cheema@ucl.ac.uk;
  Qi Zhang, zhangqi1@hmc.edu.cn;
  *De-Chao Feng, dechao.feng@ucl.ac.uk;
- Funds：
- DOI：10.1016/j.mmr.2026.100038
  CLC：
- Received：13 August 2025，
  
  Accepted：26 April 2026，
  
  Published：2026-05
- Accepted：
Scan QR Code
Wang ZP, Li AQ, Wusiman D, Wu RC, Zhu JM, Li XR, et al. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy. Mil Med Res. 2026;13(1):100038.
DOI：

Wang ZP, Li AQ, Wusiman D, Wu RC, Zhu JM, Li XR, et al. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy. Mil Med Res. 2026;13(1):100038. DOI： 10.1016/j.mmr.2026.100038.

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer

Cell-free DNA in sepsis: from molecular insights to clinical management

Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study

TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

Related Author

Lu Tang

Zhong-Pei Huang

Heng Mei

Yu Hu

Related Institution

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease

Key Laboratory of Biological Targeted Therapy, the Ministry of Education

Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

⁰

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy

DOI：10.1016/j.mmr.2026.100038